Hudock, Inc. Sqz Biotechnologies CO Transaction History

Hudock, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$4.01 - $10.42 $601 - $1,563	-150 Reduced 30.0%	350 $1,000
Q3 2021 Nov 09, 2021	SELL	$11.46 - $15.77 $435 - $599	-38 Reduced 7.06%	500 $7,000
Q2 2021 Aug 09, 2021	SELL	$11.32 - $14.45 $701 - $895	-62 Reduced 10.33%	538 $7,000
Q1 2021 Apr 26, 2021	BUY	$12.07 - $29.9 $3,017 - $7,475	250 Added 71.43%	600 $8,000
Q4 2020 Feb 05, 2021	BUY	$13.25 - $34.58 $4,637 - $12,103	350 New	350 $10,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.